Oneview Healthcare Plc (ONE) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It provides digital tools for patients, families and caregivers to improve their care experience. Unifying a facility's systems, content and services into one digital platform with devices at the point of care. The Company is partners with healthcare systems in the US, Australia, Ireland, the Middle East and Asia to unify the care experience, in over 80 hospitals.
| ASX Code | ONE |
| Website | http://www.oneviewhealthcare.com |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 142 |
| ONE Share Price | $0.170 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.170 |
| ONE Share Price Movement | - ( No change ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Final | 0.1¢ | 100% | 23 Aug 1999 | 10 Sep 1999 | - | - | - |
See all dividends from Oneview Healthcare Plc (ONE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Dec | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$22.07 | -$2.90 | 8.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$18.14 | -$2.70 | 7.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$14.45 | -$2.50 | -24.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| 4DMedical Limited (4DX) | $2,274M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Oneview Healthcare Plc (ONE) | $143M | 0.0868 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $20,774M | 1.3034 | -0.2921 | 0.2934 | 78.4109 | 110.7614 | 85.6374 | 0.35% | 0.46% | 0.60% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 20.50 | 0.00 |
| Market | 0.36 | 13.10 | 1.15 | 0.76 |
| Sector | 0.94 | 18.80 | 1.69 | 2.09 |
| Name | Position | Start Date |
|---|---|---|
| Mr James Fitter | Chief Executive Officer, Executive Director | 9 Jan 2013 |
| Mr Darragh Lyons | Chief Financial Officer, Executive Director | 9 Sep 2024 |
| Ms Barbara Nelson | Non-Executive Chairman, Non-Executive Director | 1 Oct 2023 |
| Mr Joseph Rooney | Non-Executive Director | 7 Feb 2016 |
| Mr Mark Cullen | Non-Executive Director | 1 Oct 2023 |
| Ms Nashina Asaria | Non-Executive Director | 10 May 2021 |
| Mr Michael J Dowling | Non-Executive Director | 2 Dec 2025 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Nov 2025 | CULLEN, Mark | Buy | Direct Shares | 234,375 | $0.265 | $62,109.000 |
| 15 Nov 2025 | ROONEY, Joseph | Buy | Direct Shares | 234,375 | $0.265 | $62,109.000 |
| 15 Nov 2025 | ASARIA, Nashina | Buy | Direct Shares | 156,250 | $0.265 | $41,406.000 |
See all changes in directors' interest & trades for Oneview Healthcare Plc (ONE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| JP Howe | Chief Operating Officer |
| Niall O'Neill | Chief Product Officer |
| Declan Bright | Chief Technology Officer |
| Toni Pettit | Company Secretary |
| Aoife Meehan | HR Director |
| Gabi Mitchell | VP of Clinical Innovation |
| Aaron Box | VP, Strategy & Innovation |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Oneview Healthcare Plc (ONE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 312,210,110 (40.69%) | James (Will) Vicars |
| 62,642,075 (8.40%) | FIL Limited and the entities |
| 38,152,973 (5.01%) | Christopher Duckett White |
| Date | Event |
|---|---|
| 25 March 2027 | Report (Annual) |
| 11 February 2027 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.